Testimonials
I already received my parcel, I had a problem as the courier wanted to deliver
to my home as they claim they cannot place the order into my postbox. This was
my preferred option.
There is not someone at home always, so we had to get the parcel to my office.
No problem with that.
I did have an enquiry into the 4 extra pills, and this was delivered within a
few days via airmail to my post box.
I would suggest you attend to this part of your process as the extra cost is
unnecessary. Include everything into one parcel.
All in all, good service.
- Jan
Call us toll free:
News
- UCL spinout takes nano-enabled pain therapy to international markets - MTBeurope
UCL spinout takes nano-enabled pain therapy to international marketsMTBeuropeThe UK Nanotechnology Knowledge Transfer Network (NanoKTN) has announced that member company Nanomerics, a spin-out from UCL School of Pharmacy, is taking its patented nano-enabled therapeutic technology to international markets.
- Applied DNA Sciences installs first pharmacy security system - Securing Pharma
Applied DNA Sciences installs first pharmacy security systemSecuring PharmaApplied DNA Sciences has installed its smartDNA anti-intruder mist system at a pharmacy in Long Island, USA, in response to a spate of pharmacy robberies there in recent months.
- Skepticism grows around Medco/Express Scripts deal - Reuters
WGN RadioSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the .
- Memo offers new account of ATF agent's NY shooting - USA TODAY
USA TODAYMemo offers new account of ATF agent's NY shootingUSA TODAYGARDEN CITY, NJ (AP) – A document accidentally posted on a prosecutor's website cites a pharmacist's version of the friendly fire shooting death of a federal agent during a New Year's Eve robbery and differs from an account offered by an attorney for .
- FDA approves first Cushing's syndrome drug, Corcept's Korlym - The Pharma Letter
FDA approves first Cushing's syndrome drug, Corcept's KorlymThe Pharma LetterShares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.
![]() |
Bookmark this site |
|---|
![]() |
Subscribe to the News |
|---|
![]() | Sitemap |
|---|





$0.80























